AI assistant
Sending…
Eton Pharmaceuticals, Inc. — Director's Dealing 2018
Nov 16, 2018
32663_dirs_2018-11-15_af5672b1-381a-4f71-a76a-1c4130a304a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Eton Pharmaceuticals, Inc. (ETON)
CIK: 0001710340
Period of Report: 2018-11-15
Reporting Person: BAUM MARK L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-15 | Common Stock | P | 10000 | $6.00 | Acquired | 10000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 784745 | Direct |
More from Eton Pharmaceuticals, Inc.
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 14
Earnings Release
2026
May 14
Regulatory Filings
2026
Apr 27
Board/Management Information
2026
Apr 16
Annual Report
2026
Mar 19
Earnings Release
2026
Mar 19
Capital/Financing Update
2026
Mar 2
Regulatory Filings
2026
Feb 25
Director's Dealing
2026
Feb 5